New Treatments for Alzheimer's Disease and Dementia

Join Dr. Mohamed Elkasaby of University Hospitals Neurological Institute’s Parkinson’s Disease and Movement Disorders Center as he discusses both Lecanemab and Donanemab infusion therapy, and how they have shown promise in clinical trials, and may be a treatment option for patients with mild cognitive impairment and mild dementia due to Alzheimer’s disease.

More Information

• Learn more about Lecanemab for Alzheimer’s.
• Schedule an appointment with a UH Alzheimer’s specialist.